Global Psoriatic Arthritis (PsA) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 918326 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Nonsteriodal Anti-inflammatory Drugs
        1.2.3 Disease Modifying Antirheumatic Drugs
        1.2.4 Biologics
    1.3 Market by Application
        1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2016-2027)
    2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Regions
        2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Psoriatic Arthritis (PsA) Treatment Industry Dynamic
        2.3.1 Psoriatic Arthritis (PsA) Treatment Market Trends
        2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
        2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
        2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
        3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
    3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
        3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2020
    3.5 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
    3.6 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
    3.7 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
    4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2022-2027)

5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
    5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2016-2027)
    6.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        6.2.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2027)
    6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        6.3.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2027)
    6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        6.4.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2016-2027)
    7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
        7.2.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2027)
    7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application
        7.3.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2027)
    7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country
        7.4.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type
        8.2.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application
        8.3.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region
        8.4.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2016-2027)
    9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        9.2.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        9.3.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        9.4.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type
        10.2.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application
        10.3.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country
        10.4.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
        11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
        11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.2.5 Johnson & Johnson Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
        11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.3.5 AbbVie Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
        11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 UCB
        11.5.1 UCB Company Details
        11.5.2 UCB Business Overview
        11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
        11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.5.5 UCB Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
        11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Details
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
        11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.7.5 Bristol-Myers Squibb Recent Development
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Details
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
        11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.8.5 Eli Lilly Recent Development
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
        11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.9.5 Amgen Recent Development
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
        11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.10.5 AstraZeneca Recent Development
    11.11 Celgene
        11.11.1 Celgene Company Details
        11.11.2 Celgene Business Overview
        11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
        11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
        11.11.5 Celgene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs
    Table 3. Key Players of Disease Modifying Antirheumatic Drugs
    Table 4. Key Players of Biologics
    Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2016-2021)
    Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2022-2027)
    Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends
    Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers
    Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges
    Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints
    Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2020)
    Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
    Table 22. Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Psoriatic Arthritis (PsA) Treatment Product
    Table 65. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 66. Pfizer Recent Development
    Table 67. Johnson & Johnson Company Details
    Table 68. Johnson & Johnson Business Overview
    Table 69. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product
    Table 70. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 71. Johnson & Johnson Recent Development
    Table 72. AbbVie Company Details
    Table 73. AbbVie Business Overview
    Table 74. AbbVie Psoriatic Arthritis (PsA) Treatment Product
    Table 75. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 76. AbbVie Recent Development
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Psoriatic Arthritis (PsA) Treatment Product
    Table 80. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 81. Novartis Recent Development
    Table 82. UCB Company Details
    Table 83. UCB Business Overview
    Table 84. UCB Psoriatic Arthritis (PsA) Treatment Product
    Table 85. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 86. UCB Recent Development
    Table 87. Roche Company Details
    Table 88. Roche Business Overview
    Table 89. Roche Psoriatic Arthritis (PsA) Treatment Product
    Table 90. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 91. Roche Recent Development
    Table 92. Bristol-Myers Squibb Company Details
    Table 93. Bristol-Myers Squibb Business Overview
    Table 94. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product
    Table 95. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 96. Bristol-Myers Squibb Recent Development
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 100. Eli Lilly Recent Development
    Table 101. Amgen Company Details
    Table 102. Amgen Business Overview
    Table 103. Amgen Psoriatic Arthritis (PsA) Treatment Product
    Table 104. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 105. Amgen Recent Development
    Table 106. AstraZeneca Company Details
    Table 107. AstraZeneca Business Overview
    Table 108. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product
    Table 109. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 110. AstraZeneca Recent Development
    Table 111. Celgene Company Details
    Table 112. Celgene Business Overview
    Table 113. Celgene Psoriatic Arthritis (PsA) Treatment Product
    Table 114. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2016-2021) & (US$ Million)
    Table 115. Celgene Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Nonsteriodal Anti-inflammatory Drugs Features
    Figure 3. Disease Modifying Antirheumatic Drugs Features
    Figure 4. Biologics Features
    Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Psoriatic Arthritis (PsA) Treatment Report Years Considered
    Figure 10. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2022-2027)
    Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2020
    Figure 15. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2020
    Figure 17. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2016-2027)
    Figure 21. North America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2016-2027)
    Figure 22. North America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2016-2027)
    Figure 23. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Type (2016-2027)
    Figure 27. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Application (2016-2027)
    Figure 28. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Country (2016-2027)
    Figure 29. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Region (2016-2027)
    Figure 39. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 60. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 61. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 62. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 63. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 65. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 66. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 67. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 68. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Frequently Asked Questions
Psoriatic Arthritis (PsA) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Psoriatic Arthritis (PsA) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Psoriatic Arthritis (PsA) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Digital Vault

Market Analysis and Insights: Global Digital Vault Market
The global Digital Vault  ... Read More